Concerning advanced MTC, the tumor-specific markers Ct and CEA, specifically their doubling time, are highly predictive of both survival and disease progression [83,84], and, due to the absence of antibody interference issues, may be considered as more reliable as compared with Tg. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.